PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.\', \'Pfizer, 401 N. Middletown Rd., Pearl River, NY 10960, USA.\', \'BioNTech, An der Goldgrube 12, 55131 Mainz, Germany. ugur.sahin@biontech.de.\', \'TRON gGmbH - Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Freiligrathstraße 12, 55131 Mainz, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/science.abg6105
?:doi
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 33514629
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all